Procter & Gamble Q2 FY2026 Core EPS Tops Forecasts as Revenue Misses Expectations

Procter & Gamble reported fiscal Q2 2026 net sales of $22.2 billion and core EPS of $1.88, with earnings slightly ahead of market estimates but revenue below consensus. The company kept its full‑year 2026 guidance for sales and core EPS growth, while trimming its outlook for diluted EPS growth due to higher restructuring charges. It also projected neutral commodity costs, a positive after‑tax currency benefit of about $200 million, and roughly $400 million in tariff‑related after‑tax costs for the fiscal year.